Real Time Vital Sign Assessment to Predict Neurological Decline After Traumatic Brain Injury
RAPID-TBI
1 other identifier
observational
1,200
1 country
1
Brief Summary
This study will look to validate predictive algorithms developed in a previous study where we collected relevant data from trauma registry and after using advanced signal-processing and machine-learning, determined prediction scores regarding neuroworsening and other outcomes following traumatic brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2021
CompletedFirst Submitted
Initial submission to the registry
September 27, 2021
CompletedFirst Posted
Study publicly available on registry
October 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
ExpectedMay 15, 2025
May 1, 2025
4.8 years
September 27, 2021
May 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Neurological Decline
Neurological decline is defined as a worsening in neurological status determined by a 2 point decline GCS, pupillary change, radiographic worsening defined by Rotterdam score, need for neurological or neurosurgical intervention (eg. treatment of seizure, raised ICP, hematoma evacuation)
First 48 hours of injury
Eligibility Criteria
Adult TBI patients
You may qualify if:
- Arrival to the hospital within 6 hours of injury
- Age \>= 18 years old
- Patients with traumatic brain injury(TBI). TBI is defined as any alteration or loss of consciousness with or without positive head C.T findings.
You may not qualify if:
- Deemed to have a non-survivable TBI
- Brain dead on arrival
- Active substance abuse for opiates and cocaine as noted by admission toxicology screen.
- Any thoracic or abdominal injury resulting in open surgical intervention
- Pregnancy
- Prisoners
- Active military
- Non - English speaking (due to necessity for consent in aims 2 and 3)
- Age \> 89 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Maryland Medical Center
Baltimore, Maryland, 21210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Neurology
Study Record Dates
First Submitted
September 27, 2021
First Posted
October 19, 2021
Study Start
March 29, 2021
Primary Completion
December 31, 2025
Study Completion (Estimated)
October 31, 2026
Last Updated
May 15, 2025
Record last verified: 2025-05